Recent COCP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2025 12:00:21 PM
- Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants • GlobeNewswire Inc. • 04/24/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2025 09:00:42 PM
- Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference • GlobeNewswire Inc. • 04/16/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2025 08:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2025 08:30:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 12:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2025 12:30:23 PM
- Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs • GlobeNewswire Inc. • 03/31/2025 12:00:00 PM
- Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/14/2025 12:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:00:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2025 01:30:38 PM
- Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections • GlobeNewswire Inc. • 01/08/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/31/2024 01:30:12 PM
- Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344 • GlobeNewswire Inc. • 12/31/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 08:30:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 01:30:37 PM
- Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs • GlobeNewswire Inc. • 11/13/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 01:10:00 PM
- Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins • GlobeNewswire Inc. • 10/31/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 08:06:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 08:05:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 08:05:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 08:05:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 09:02:21 PM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com • INND • Apr 24, 2025 8:00 AM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM